MedTrace Logo

Assessment of Thrombogenicity in Acute Coronary Syndrome

NCT00728286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2015-10-12

No results posted yet for this study

Summary

The purpose of this study is to assess platelet dependent thrombogenicity in patients after acute coronary syndrome using an ex vivo arterial injury model.

Conditions

Sponsors & Collaborators

  • British Heart Foundation

    collaborator OTHER

  • University of Newcastle Upon-Tyne

    collaborator OTHER

  • Newcastle-upon-Tyne Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Azfar G Zaman, MD FRCP · Freeman Hospital, Newcastle upon Tyne NHS Trust, Newcastle upon Tyne. NE7 7DN

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-01-31
Completion
2011-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00728286 on ClinicalTrials.gov